Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boshoff

Showing results (541-550 of 568) with videos related to

Pageof 57
Sort By:
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of <i>Mycobacterium tuberculosis</i>Simon R Green, Justin R Harrison, Stephen Thompson, et al.
Journal of Medicinal Chemistry|November 10, 2023
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular ActivitySimon R Green, Caroline Wilson, Thomas C Eadsforth, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Nature Medicine|January 28, 2014
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug effluxRichard E Lee, Julian G Hurdle, Jiuyu Liu, et al.
BMJ Open|October 16, 2024
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trialsJessica Griffiths, Fiona Adshead, Rustam Al-Shahi Salman, et al.
Elife|September 11, 2015
Geological and taphonomic context for the new hominin species Homo naledi from the Dinaledi Chamber, South AfricaPaul H G M Dirks, Lee R Berger, Eric M Roberts, et al.
Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
Science (New York, N.Y.)|March 27, 2025
A wheat tandem kinase activates an NLR to trigger immunityRenjie Chen, Jian Chen, Oliver R Powell, et al.
Nature Communications|January 9, 2021
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric siteVitor Mendes, Simon R Green, Joanna C Evans, et al.
Pageof 57

Showing results (541-550 of 568) with videos related to

Sort By:
Pageof 57
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of <i>Mycobacterium tuberculosis</i>Simon R Green, Justin R Harrison, Stephen Thompson, et al.
Journal of Medicinal Chemistry|November 10, 2023
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular ActivitySimon R Green, Caroline Wilson, Thomas C Eadsforth, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Nature Medicine|January 28, 2014
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug effluxRichard E Lee, Julian G Hurdle, Jiuyu Liu, et al.
BMJ Open|October 16, 2024
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trialsJessica Griffiths, Fiona Adshead, Rustam Al-Shahi Salman, et al.
Elife|September 11, 2015
Geological and taphonomic context for the new hominin species Homo naledi from the Dinaledi Chamber, South AfricaPaul H G M Dirks, Lee R Berger, Eric M Roberts, et al.
Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
Science (New York, N.Y.)|March 27, 2025
A wheat tandem kinase activates an NLR to trigger immunityRenjie Chen, Jian Chen, Oliver R Powell, et al.
Nature Communications|January 9, 2021
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric siteVitor Mendes, Simon R Green, Joanna C Evans, et al.
Pageof 57